Welcome to our dedicated page for Churchill Cap X SEC filings (Ticker: CCCXW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Churchill Cap X's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Churchill Cap X's regulatory disclosures and financial reporting.
Churchill Capital Corp X has filed an amended Form S-4 for its proposed business combination with quantum technology company ColdQuanta, Inc. (d/b/a Infleqtion). This proxy statement/prospectus covers up to 244,463,410 shares of common stock of the post-closing company to be issued in connection with the merger and related transactions.
The deal values Infleqtion at an equity value of $1.8 billion, to be paid entirely in post-closing common stock at $10.00 per share, with an estimated exchange ratio of about 0.347 post-closing shares for each Infleqtion common share. CCX has also arranged a $126,547,600 PIPE investment at $10.00 per share to help fund the transaction.
Following the deal, CCX will domesticate from the Cayman Islands to Delaware and be renamed Infleqtion, Inc. Pro forma, Infleqtion stockholders are expected to hold the majority of the combined company, with SPAC public holders, the sponsor and PIPE investors owning the balance under various redemption scenarios. The CCX board unanimously approved the merger and received a fairness opinion supporting the purchase price.
Churchill Capital Corp X has filed an amended Form S-4 for its proposed business combination with quantum technology company ColdQuanta, Inc. (d/b/a Infleqtion). This proxy statement/prospectus covers up to 244,463,410 shares of common stock of the post-closing company to be issued in connection with the merger and related transactions.
The deal values Infleqtion at an equity value of $1.8 billion, to be paid entirely in post-closing common stock at $10.00 per share, with an estimated exchange ratio of about 0.347 post-closing shares for each Infleqtion common share. CCX has also arranged a $126,547,600 PIPE investment at $10.00 per share to help fund the transaction.
Following the deal, CCX will domesticate from the Cayman Islands to Delaware and be renamed Infleqtion, Inc. Pro forma, Infleqtion stockholders are expected to hold the majority of the combined company, with SPAC public holders, the sponsor and PIPE investors owning the balance under various redemption scenarios. The CCX board unanimously approved the merger and received a fairness opinion supporting the purchase price.
Churchill Capital Corp X reporting persons (Churchill Sponsor X LLC, M. Klein Associates, Inc. and Michael Klein) filed Amendment No. 1 to a Schedule 13D reporting beneficial ownership of 10,650,000 ordinary shares, representing 20.4% of the Class A ordinary shares (includes 300,000 Class A and 10,350,000 Class B convertible one-for-one on closing).
The amendment discloses a definitive Merger Agreement to combine Churchill with ColdQuanta, Inc. through a two-step merger and related Transactions, including a $126,547,600 PIPE at $10.00 per share. It also describes an Amended and Restated Registration Rights Agreement with specified resale registration timing, an Amended and Restated Sponsor Agreement with 1,500,000 sponsor shares that vest upon a $12 VWAP trigger or change of control, and an Advisory Agreement paying a $250,000 quarterly retainer to The Klein Group.
Churchill Capital Corp X reporting persons (Churchill Sponsor X LLC, M. Klein Associates, Inc. and Michael Klein) filed Amendment No. 1 to a Schedule 13D reporting beneficial ownership of 10,650,000 ordinary shares, representing 20.4% of the Class A ordinary shares (includes 300,000 Class A and 10,350,000 Class B convertible one-for-one on closing).
The amendment discloses a definitive Merger Agreement to combine Churchill with ColdQuanta, Inc. through a two-step merger and related Transactions, including a $126,547,600 PIPE at $10.00 per share. It also describes an Amended and Restated Registration Rights Agreement with specified resale registration timing, an Amended and Restated Sponsor Agreement with 1,500,000 sponsor shares that vest upon a $12 VWAP trigger or change of control, and an Advisory Agreement paying a $250,000 quarterly retainer to The Klein Group.
Churchill Capital Corp X reporting persons (Churchill Sponsor X LLC, M. Klein Associates, Inc. and Michael Klein) filed Amendment No. 1 to a Schedule 13D reporting beneficial ownership of 10,650,000 ordinary shares, representing 20.4% of the Class A ordinary shares (includes 300,000 Class A and 10,350,000 Class B convertible one-for-one on closing).
The amendment discloses a definitive Merger Agreement to combine Churchill with ColdQuanta, Inc. through a two-step merger and related Transactions, including a $126,547,600 PIPE at $10.00 per share. It also describes an Amended and Restated Registration Rights Agreement with specified resale registration timing, an Amended and Restated Sponsor Agreement with 1,500,000 sponsor shares that vest upon a $12 VWAP trigger or change of control, and an Advisory Agreement paying a $250,000 quarterly retainer to The Klein Group.